KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcosa (ACA) Invested Capital (2017 - 2026)

Arcosa's Invested Capital history spans 10 years, with the latest figure at $4.2 billion for Q1 2026.

  • On a quarterly basis, Invested Capital rose 0.8% to $4.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $4.2 billion, a 0.8% increase, with the full-year FY2025 number at $4.2 billion, up 1.14% from a year prior.
  • Invested Capital hit $4.2 billion in Q1 2026 for Arcosa, roughly flat from $4.2 billion in the prior quarter.
  • Over the last five years, Invested Capital for ACA hit a ceiling of $4.2 billion in Q2 2025 and a floor of $2.7 billion in Q1 2022.
  • Historically, Invested Capital has averaged $3.3 billion across 5 years, with a median of $3.0 billion in 2024.
  • Biggest five-year swings in Invested Capital: surged 41.93% in 2024 and later increased 0.8% in 2026.
  • Tracing ACA's Invested Capital over 5 years: stood at $2.7 billion in 2022, then rose by 6.06% to $2.9 billion in 2023, then surged by 41.93% to $4.1 billion in 2024, then increased by 1.14% to $4.2 billion in 2025, then increased by 0.23% to $4.2 billion in 2026.
  • Business Quant data shows Invested Capital for ACA at $4.2 billion in Q1 2026, $4.2 billion in Q4 2025, and $4.2 billion in Q3 2025.